191 related articles for article (PubMed ID: 26717315)
1. Linking inflammation and hypertension via LNK/SH2B3.
Dale BL; Madhur MS
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):87-93. PubMed ID: 26717315
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation.
Saleh MA; McMaster WG; Wu J; Norlander AE; Funt SA; Thabet SR; Kirabo A; Xiao L; Chen W; Itani HA; Michell D; Huan T; Zhang Y; Takaki S; Titze J; Levy D; Harrison DG; Madhur MS
J Clin Invest; 2015 Mar; 125(3):1189-202. PubMed ID: 25664851
[TBL] [Abstract][Full Text] [Related]
3. Mutation of SH2B3 (LNK), a genome-wide association study candidate for hypertension, attenuates Dahl salt-sensitive hypertension via inflammatory modulation.
Rudemiller NP; Lund H; Priestley JR; Endres BT; Prokop JW; Jacob HJ; Geurts AM; Cohen EP; Mattson DL
Hypertension; 2015 May; 65(5):1111-7. PubMed ID: 25776069
[TBL] [Abstract][Full Text] [Related]
4. Lnk/Sh2b3 controls the production and function of dendritic cells and regulates the induction of IFN-γ-producing T cells.
Mori T; Iwasaki Y; Seki Y; Iseki M; Katayama H; Yamamoto K; Takatsu K; Takaki S
J Immunol; 2014 Aug; 193(4):1728-36. PubMed ID: 25024389
[TBL] [Abstract][Full Text] [Related]
5. A Single Nucleotide Polymorphism in
Alexander MR; Hank S; Dale BL; Himmel L; Zhong X; Smart CD; Fehrenbach DJ; Chen Y; Prabakaran N; Tirado B; Centrella M; Ao M; Du L; Shyr Y; Levy D; Madhur MS
Circ Res; 2022 Oct; 131(9):731-747. PubMed ID: 36169218
[TBL] [Abstract][Full Text] [Related]
6. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling.
Devallière J; Charreau B
Biochem Pharmacol; 2011 Nov; 82(10):1391-402. PubMed ID: 21723852
[TBL] [Abstract][Full Text] [Related]
7. The function of SH2B3 (LNK) in the kidney.
Blass G; Mattson DL; Staruschenko A
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F682-F685. PubMed ID: 27440780
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection.
Chatelais M; Devallière J; Galli C; Charreau B
Xenotransplantation; 2011; 18(2):108-20. PubMed ID: 21496118
[TBL] [Abstract][Full Text] [Related]
9. LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis.
Wang W; Tang Y; Wang Y; Tascau L; Balcerek J; Tong W; Levine RL; Welch C; Tall AR; Wang N
Circ Res; 2016 Sep; 119(6):e91-e103. PubMed ID: 27430239
[TBL] [Abstract][Full Text] [Related]
10. The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.
Maslah N; Cassinat B; Verger E; Kiladjian JJ; Velazquez L
Leukemia; 2017 Aug; 31(8):1661-1670. PubMed ID: 28484264
[TBL] [Abstract][Full Text] [Related]
11. [Sh2b3/Lnk family adaptor proteins in the regulation of lymphohematopoiesis].
Takaki S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):440-7. PubMed ID: 19122374
[TBL] [Abstract][Full Text] [Related]
12. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors.
Cheng Y; Chikwava K; Wu C; Zhang H; Bhagat A; Pei D; Choi JK; Tong W
J Clin Invest; 2016 Apr; 126(4):1267-81. PubMed ID: 26974155
[TBL] [Abstract][Full Text] [Related]
13. The Lnk adaptor protein: a key regulator of normal and pathological hematopoiesis.
Velazquez L
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):415-29. PubMed ID: 22990499
[TBL] [Abstract][Full Text] [Related]
14. [Role of LNK gene mutation in pathogenesis of myeloproliferative neoplasms-review].
Chen Y; Wu XQ; Han CS; Zhu P; Wei JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1309-12. PubMed ID: 24156456
[TBL] [Abstract][Full Text] [Related]
15. Lnk/Sh2b3 Regulates Adipose Inflammation and Glucose Tolerance through Group 1 ILCs.
Mori T; Suzuki-Yamazaki N; Takaki S
Cell Rep; 2018 Aug; 24(7):1830-1841. PubMed ID: 30110639
[TBL] [Abstract][Full Text] [Related]
16. LNK (SH2B3): paradoxical effects in ovarian cancer.
Ding LW; Sun QY; Lin DC; Chien W; Hattori N; Dong XM; Gery S; Garg M; Doan NB; Said JW; Xiao JF; Yang H; Liu LZ; Meng X; Huang RY; Tang K; Koeffler HP
Oncogene; 2015 Mar; 34(11):1463-74. PubMed ID: 24704825
[TBL] [Abstract][Full Text] [Related]
17. Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein.
Takaki S; Tezuka Y; Sauer K; Kubo C; Kwon SM; Armstead E; Nakao K; Katsuki M; Perlmutter RM; Takatsu K
J Immunol; 2003 Jan; 170(2):703-10. PubMed ID: 12517931
[TBL] [Abstract][Full Text] [Related]
18. LNK suppresses interferon signaling in melanoma.
Ding LW; Sun QY; Edwards JJ; Fernández LT; Ran XB; Zhou SQ; Scolyer RA; Wilmott JS; Thompson JF; Doan N; Said JW; Venkatachalam N; Xiao JF; Loh XY; Pein M; Xu L; Mullins DW; Yang H; Lin DC; Koeffler HP
Nat Commun; 2019 May; 10(1):2230. PubMed ID: 31110180
[TBL] [Abstract][Full Text] [Related]
19. Lnk prevents inflammatory CD8⁺ T-cell proliferation and contributes to intestinal homeostasis.
Katayama H; Mori T; Seki Y; Anraku M; Iseki M; Ikutani M; Iwasaki Y; Yoshida N; Takatsu K; Takaki S
Eur J Immunol; 2014 Jun; 44(6):1622-32. PubMed ID: 24536025
[TBL] [Abstract][Full Text] [Related]
20. The carriage of the type 1 diabetes-associated R262W variant of human LNK correlates with increased proliferation of peripheral blood monocytes in diabetic patients.
Lavrikova EY; Nikitin AG; Kuraeva TL; Peterkova VA; Tsitlidze NM; Chistiakov DA; Nosikov VV
Pediatr Diabetes; 2011 Mar; 12(2):127-32. PubMed ID: 20546165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
